{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:21:12Z","timestamp":1785766872340,"version":"3.56.0"},"reference-count":44,"publisher":"Bioscientifica","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>Growth hormone (GH) is used to treat short stature and growth failure associated with growth disorders. Birth size and GH status variably modulate response to GH therapy. The aim of this study was to determine the effect of birth size on response to GH therapy, and to determine the impact of GH status in patients born small for gestational age (SGA) on response to GH therapy. Data from the prospective, non-interventional American Norditropin Studies: Web-Enabled Research (ANSWER) Program was analyzed for several growth outcomes in response to GH therapy over 3 years. GH-na\u00efve children from the ANSWER Program were included in this analysis: SGA with peak GH \u226510\u2009ng\/mL (20\u2009mIU\/L), SGA with peak GH &lt;10\u2009ng\/mL (20\u2009mIU\/L), isolated growth hormone deficiency (IGHD) born SGA, IGHD not born SGA and idiopathic short stature. For patients with IGHD, those who did not meet criteria for SGA at birth showed greater improvements in height SDS and BMI SDS than patients with IGHD who met criteria for SGA at birth. For patients born SGA, response to GH therapy varied with GH status. Therefore, unlike previous guidelines, we recommend that GH status be established in patients born SGA to optimize GH therapy.<\/jats:p>","DOI":"10.1530\/ec-18-0286","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T09:45:15Z","timestamp":1535017515000},"page":"1096-1104","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":15,"title":["Three years of growth hormone therapy in children born small for gestational age: results from the ANSWER Program"],"prefix":"10.1530","volume":"7","author":[{"given":"Robert","family":"Rapaport","sequence":"first","affiliation":[{"name":"1Ichan School of Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Lee","sequence":"additional","affiliation":[{"name":"2Penn State College of Medicine, Hershey, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L","family":"Ross","sequence":"additional","affiliation":[{"name":"3Thomas Jefferson University, Philadelphia, Pennsylvania, USA"},{"name":"4Nemours\/DuPont Hospital for Children, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saenger","sequence":"additional","affiliation":[{"name":"5Winthrop University Hospital, Mineola, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlady","family":"Ostrow","sequence":"additional","affiliation":[{"name":"6Novo Nordisk Inc., Plainsboro, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Piccoli","sequence":"additional","affiliation":[{"name":"6Novo Nordisk Inc., Plainsboro, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref381","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1687-9856-2011-6","article-title":"Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program(R)","volume":"2011","year":"2011","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"852967","DOI":"10.1186\/1687-9856-2010-852967","article-title":"The auxological and biochemical continuum of short children born small for gestational age (SGA) or with normal birth size (idiopathic short stature)","volume":"2010","year":"2010","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF03346369","article-title":"Recombinant human growth hormone for children born small for gestational age: meta-analysis confirms the consistent dose-effect relationship on catch-up growth","volume":"31","year":"2008","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF03346369","article-title":"Recombinant human growth hormone for children born small for gestational age: meta-analysis confirms the consistent dose-effect relationship on catch-up growth","volume":"31","year":"2008","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref351","first-page":"CD004440","article-title":"Recombinant growth hormone for idiopathic short stature in children and adolescents","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1687-9856-2012-15","article-title":"Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program(R) registry","volume":"2012","year":"2012","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref221","article-title":"Cartridges somatropin rDNA origin injection for Subcutaneous Use prescribing information Princeton","author":"Novo Nordisk","year":"2016","journal-title":"USA"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","year":"2016","journal-title":"Hormone Research in Paediatrics"},{"key":"ref361","doi-asserted-by":"publisher","first-page":"2009124","DOI":"10.1542\/peds.2009-0293","article-title":"MaioranaACianfaraniS Impact of growth hormone therapy on adult height of children born small for gestational age https org","journal-title":"Pediatrics"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","article-title":"Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee","volume":"143","year":"2003","journal-title":"Journal of Pediatrics"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000098707","article-title":"Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature","volume":"68","year":"2007","journal-title":"Hormone Research"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"852967","DOI":"10.1186\/1687-9856-2010-852967","article-title":"The auxological and biochemical continuum of short children born small for gestational age (SGA) or with normal birth size (idiopathic short stature)","volume":"2010","year":"2010","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000281323","article-title":"Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone dose-response trial","volume":"74","year":"2010","journal-title":"Hormone Research in Paediatrics"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000281323","article-title":"Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone dose-response trial","volume":"74","year":"2010","journal-title":"Hormone Research in Paediatrics"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1687-9856-2011-6","article-title":"Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program(R)","volume":"2011","year":"2011","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref371","doi-asserted-by":"publisher","first-page":"2010125","DOI":"10.1542\/peds.2009-1783","article-title":"advisory panel meeting on the effects of growth hormone hormone health considerations beyond height gain https org","journal-title":"Growth Pediatrics"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","year":"2016","journal-title":"Hormone Research in Paediatrics"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000071871","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","year":"2003","journal-title":"Hormone Research"},{"key":"ref431","doi-asserted-by":"publisher","first-page":"201216","DOI":"10.4103\/2230-8210.104034","article-title":"The variability of responses to growth hormone therapy in children with short stature of and https org","author":"SavageMOBangP","journal-title":"Journal Endocrinology Metabolism"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"2009124","DOI":"10.1542\/peds.2009-0293","article-title":"MaioranaACianfaraniS Impact of growth hormone therapy on adult height of children born small for gestational age https org","journal-title":"Pediatrics"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","article-title":"Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society","volume":"92","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000322878","article-title":"A comparison of different definitions of growth response in short prepubertal children treated with growth hormone","volume":"75","year":"2011","journal-title":"Hormone Research in Paediatrics"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000322878","article-title":"A comparison of different definitions of growth response in short prepubertal children treated with growth hormone","volume":"75","year":"2011","journal-title":"Hormone Research in Paediatrics"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13633-015-0015-1","article-title":"Noonan syndrome and Turner syndrome patients respond similarly to 4 years\u2019 growth-hormone therapy: longitudinal analysis of growth-hormone-naive patients enrolled in the NordiNet(R) International Outcome Study and the ANSWER Program","volume":"2015","year":"2015","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13633-015-0015-1","article-title":"Noonan syndrome and Turner syndrome patients respond similarly to 4 years\u2019 growth-hormone therapy: longitudinal analysis of growth-hormone-naive patients enrolled in the NordiNet(R) International Outcome Study and the ANSWER Program","volume":"2015","year":"2015","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"494656","DOI":"10.1186\/1687-9856-2010-494656","article-title":"Factors influencing the one- and two-year growth response in children treated with growth hormone: analysis from an observational study","volume":"2010","year":"2010","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1687-9856-2015-1","article-title":"Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program","volume":"2015","year":"2015","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000098707","article-title":"Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature","volume":"68","year":"2007","journal-title":"Hormone Research"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","article-title":"Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society","volume":"92","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","article-title":"Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study","volume":"84","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jc.2002-020867","article-title":"Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","article-title":"Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee","volume":"143","year":"2003","journal-title":"Journal of Pediatrics"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1687-9856-2012-15","article-title":"Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program(R) registry","volume":"2012","year":"2012","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jc.2002-020867","article-title":"Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ghir.2015.08.006","article-title":"Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years","volume":"25","year":"2015","journal-title":"Growth Hormone and IGF Research"},{"key":"ref91","first-page":"CD004440","article-title":"Recombinant growth hormone for idiopathic short stature in children and adolescents","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"201216","DOI":"10.4103\/2230-8210.104034","article-title":"The variability of responses to growth hormone therapy in children with short stature of and https org","author":"SavageMOBangP","journal-title":"Journal Endocrinology Metabolism"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1687-9856-2015-1","article-title":"Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program","volume":"2015","year":"2015","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ghir.2015.08.006","article-title":"Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years","volume":"25","year":"2015","journal-title":"Growth Hormone and IGF Research"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000071871","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","year":"2003","journal-title":"Hormone Research"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","article-title":"Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study","volume":"84","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"494656","DOI":"10.1186\/1687-9856-2010-494656","article-title":"Factors influencing the one- and two-year growth response in children treated with growth hormone: analysis from an observational study","volume":"2010","year":"2010","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"ref481","article-title":"Cartridges somatropin rDNA origin injection for Subcutaneous Use prescribing information Princeton","author":"Novo Nordisk","year":"2016","journal-title":"USA"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2010125","DOI":"10.1542\/peds.2009-1783","article-title":"advisory panel meeting on the effects of growth hormone hormone health considerations beyond height gain https org","journal-title":"Growth Pediatrics"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/7\/10\/EC-18-0286.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/7\/10\/EC-18-0286.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:43:02Z","timestamp":1784554982000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/7\/10\/1096-1104\/369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":44,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1530\/ec-18-0286","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}